Stay updated on Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded New York as a location under the Locations section and updated the page to revision 3.3.3; the old 'New York Locations' listing and the 'HHS Vulnerability Disclosure' footer link were removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedUpdated revision from v3.2.0 to v3.3.2; no study details or outcomes appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe notice about government funding and operating status was removed from the page, eliminating an informational banner unrelated to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedNo significant changes to the study details or criteria were observed between versions; the changes appear to be limited to formatting/layout.SummaryDifference0.5%

- Check91 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus updated to v3.2.0.SummaryDifference3%

- Check98 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; core content and user-facing data remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Radiotherapy in Glioblastoma Clinical Trial page.